LPH II Investments Ltd 4/A
4/A · WINDTREE THERAPEUTICS INC /DE/ · Filed Dec 26, 2018
Insider Transaction Report
Form 4/AAmended
LPH II Investments Ltd
10% Owner
Transactions
- Purchase
Series F Warrants
2018-12-21+307,859→ 1,040,886 totalExercise: $3.68From: 2018-12-24Exp: 2020-05-24→ Common Stock (307,859 underlying) - Purchase
Common Stock
2018-12-21$3.31/sh+1,810,938$5,994,205→ 2,352,605 total - Purchase
Series G Warrants
2018-12-21+597,610→ 1,040,886 totalExercise: $4.05From: 2018-12-24Exp: 2023-12-24→ Common Stock (597,610 underlying)
Footnotes (2)
- [F1]On December 22, 2017, the Issuer effected a 1-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
- [F2]Effective December 21, 2018 the Issuer entered into a Securities Purchase Agreement with certain investors ("Investors") (the "Financing") whereby LPH II Investments Limited ("LPH II"), a wholly owned subsidiary of the Reporting Person, converted $6.0 million of existing debt obligations in the Financing on the same terms as the Investors. The Issuer issued and LPH II received (i) 1,810,938 shares of Common Stock (ii) 307,859 Series F Warrants to purchase 307,859 shares of Common Stock at an exercise price of $3.68 per share and (iii) 597,610 Series G Warrants (with the Series F Warrants the "Financing Warrants") to purchase 597,610 shares of Common Stock at an exercise price of $4.05 per share. Accordingly, LPH II is deemed to beneficially own (i)1,810,938 shares of Common Stock (ii) 307,859 shares of Common Stock issuable upon exercise of the Series F Warrants and (iii) 597,610 shares of Common Stock issuable upon exercise of the Series G Warrants.